So it's 10pm and I'm busy here putting the final touches to the AMRC/INVOLVE report of the workshop we held in November which drew together patient views on health research regulation. This was at the invitation of the Academy of Medical Sciences as part of their review of regulation and governance but - and all … Continue reading An evening of industry – how the pharma business model is changing
venture capitalist
Science at the Labour Party Conference – a Miller's tale
Rumour has it that there is an outbreak of tonsilitis in the north-west at the moment...here's hoping Ed Milliband is being kept in isolation until his leader's speech this afternoon. One thing I forgot to mention from last night's meeting was David Lammy's comment that the coalition government has yet to put together a convincing narrative for … Continue reading Science at the Labour Party Conference – a Miller's tale
Venture capitalists weigh in on science funding debate
I spoke at an interesting event last week organised by OneNucleus, a membership organisation which brings together international life science and healthcare companies. The audience was packed with representatives of both large and small companies including many biotechs. It was the day before Vince Cable's speech and much concern about what he would or would not … Continue reading Venture capitalists weigh in on science funding debate
Simon Denegri's Lay Review 